glp 1 news today More GLP-1 news: in a late-stage study in type 2 diabetes and elevated cardiovascular risk, our new GLP-1 pill showed cardiovascular safety. Read more: https://e.lilly/4myJlm8 Health insurer Cigna will stop
Description
GLP-1, or Glucagon-Like Peptide-1, is a fascinating hormone that plays a vital role in how our bodies manage appetite and process glucose
OR = 4.44 [2.438.15])
Expanding options for patients Widening the pool of available options beyond injectables could help meet consumer demand more effectively
The development of reliable biomarkers is also critical for monitoring therapeutic response and advancing clinical translation
Health Canada says it is actively monitoring the marketplace and continuing to take action such as seizures and the issuance of compliance or warning letters against the sale and advertisement of these products in stores and online [Source: recalls-rappels.canada.ca/en/alert-recall/thinking-about-buying-glp-1-drugs-ozempic-or-mounjaro-beware-fake-or-unauthorized]
